Galapagos NV (NASDAQ:GLPG)
| 42.88 Delayed Data As of May 26 |  -0.26 / -0.60%Today’s Change | 36.17 Today|||52-Week Range 58.67 | -3.38% Year-to-Date |
Latest GLPG News | Press Releases
No recent news for Galapagos NV.
Today’s Trading
| Previous close | 43.14 |
| Today’s open | 43.19 |
| Day’s range | 42.87 - 43.41 |
| Volume | 4,224 |
| Average volume (3 months) | 276,614 |
| Market cap | $2.8B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -54.08% |
| Earnings growth (this year) | +39.25% |
| Earnings growth (next 5 years) | +7.68% |
| Revenue growth (last year) | -7.34% |
| P/E ratio | NM |
| Price/Sales | 5.49 |
| Price/Book | 1.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBHPrestige Consumer He... | +0.64 | +1.10% |
| BHCValeant Pharmaceutic... | -0.06 | -0.73% |
| SAGESAGE Therapeutics In... | +1.07 | +2.18% |
| INSMInsmed Inc | +0.10 | +0.53% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 4, 2023 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $531.0M |
| Annual profit (last year) | -$229.1M |
| Net profit margin | -43.14% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mechelen, Brussels Region |
Forecasts
